RAS mt disease
MSS RAS mt mCRC
stratification of MSS RAS mt patients
RAS mutant
described MSS RAS mt classifiers
new MSS RAS mt  specific subtypes
RAS wild-type CRC patients
harbour RAS mutations
novel patient stratification tools
patient stratification solutions Colorectal cancer
Patient associations
total CRC cases
novel classifiers
metastatic Colorectal Cancer
disease-mechanism
complex disease
common cancer
novel concepts
Current treatment
impact of assays
targets
high economic impact
limited treatment options
art pre-clinical patient derived xenograft studies
high prevalence
targeted treatment of microsatellite stable
viable assays
COLOSSUS trial
new actionable pathways
power of systems biomedicine
computational modelling
need
outcome prediction
network analysis
longitudinal omics data
commercialisation opportunities
unique signalling dependences
Precision Medicine Paradigm
personalised therapeutic interventions
biomarkers
state
therapy optimization strategies
regulatory aspects
proposal
cancers
participating SMEs
healthcare costs
setting
consortium
Europe
global context
fluoruracil
chemotherapy
bevacizumab
SME partners
related deaths
recent years